|
|
|
|
|
Detail |
| hsa-miR-103 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. |
2007 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Cerebellar neurodegeneration in the absence of microRNAs. |
2007 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. |
2006 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. |
2008 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-103 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|